<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-Y8EFH4AI</identifier><date>2000</date><creator>Jezeršek Novaković, Barbara</creator><creator>Novaković, Srdjan</creator><relation>documents/doc/Y/URN_NBN_SI_doc-Y8EFH4AI_001.pdf</relation><relation>documents/doc/Y/URN_NBN_SI_doc-Y8EFH4AI_001.txt</relation><format format_type="issue">3</format><format format_type="volume">34</format><format format_type="type">article</format><format format_type="extent">str. 301-306</format><identifier identifier_type="COBISSID">11946457</identifier><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-Y8EFH4AI</identifier><language>eng</language><publisher publisher_location="[Zagreb]">Croatian Medical Association - Croatian Society of Radiology</publisher><publisher publisher_location="Ljubljana">Slovenian Medical Society - Section of Radiology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>InC</rights><subject language_type_id="slv">Autoantibodies</subject><subject language_type_id="slv">biokemija</subject><subject language_type_id="slv">limfom</subject><subject language_type_id="slv">Lymphoma, non-Hodgkin's</subject><subject language_type_id="slv">markerji</subject><subject language_type_id="slv">onkologija</subject><subject language_type_id="slv">Prognosis</subject><subject language_type_id="slv">Protein p53</subject><subject language_type_id="slv">protitelesa</subject><subject language_type_id="slv">Tumor markers, biological</subject><title>Antibodies to p53 - can they serve as tumor markers in patients with malignant lymphomas?</title></Record>